ECS Granted Manufacture Licence For Medicinal Cannabis

  • Nov 12, 2019 AEDT
  • Team Kalkine

ECS Botanics Holdings Limited (ASX: ECS) has been granted a Manufacture Licence by the Australian Federal Government’s Department of Health Office of Drug Control (ODC) for the operations of medical cannabis at its site in Tasmania.

  • The licence allows the Company to undertake authorised activities for specified drugs upon development of its proposed medical cannabis facility at the site;
  • The licence authorises ECS to undertake the manufacture of a drug in accordance with one or more manufacture permits;
  • The licence was valid from 8 November 2019 till 8 November 2020.

At AEST 12:55PM, the stock was trading at $0.059 per share, up by 13.46% from its previous close.


All pictures are copyright to their respective owner(s) does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.


There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK